Trial
NCT02489500
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Boston Medical Center
Collaborators
—
Condition
AL Amyloidosis
Intervention
Bortezomib
Why stopped
Enrollment held for toxicity evaluation; then closed due to competing trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-10